Results 241 to 250 of about 790,262 (299)
Evaluating the influence of vaccine archetypes and epidemiological conditions on clinical trial metrics for tuberculosis vaccine candidates. [PDF]
VaccineAndrews JR +5 more
europepmc +1 more source
Pink Polypoid Papulo‐Vesicles on Labia Majora
JEADV Clinical Practice, EarlyView.
Maria Chiara Mercuri +3 more
wiley +1 more source
Miliary Tuberculosis Diagnosed After Repeated Sputum Smear Examinations Despite Negative Results at a Referral Tuberculosis Center: The Importance of Maintaining Clinical Suspicion. [PDF]
J Gen Fam MedKabeya K, Mouri K, Someko H.
europepmc +1 more source
Therapeutic Inertia in Hidradenitis Suppurativa: Could Defensive Medicine Play a Role?
JEADV Clinical Practice, EarlyView.
Anju George, Alejandro Molina‐Leyva
wiley +1 more source
Microbial Natural Products Targeting the <i>Mycobacterium tuberculosis</i> Complex: Toward the Discovery of Novel Anti-Tubercular Agents. [PDF]
MicroorganismsFolliero V +6 more
europepmc +1 more source
Nature Reviews Disease Primers, 2016 Although the worldwide incidence of tuberculosis has been slowly decreasing, the global disease burden remains substantial (∼9 million cases and ∼1·5 million deaths in 2013), and tuberculosis incidence and drug resistance are rising in some parts of the world such as Africa.
Keertan Dheda +2 more
exaly +10 more sources